仅使用超声生物物理评分对存在基础疾病的孕妇进行产前检测
该病例系列纳入2006至2018年间单一生殖医学实践机构中孕32周及以上、至少有一项美国妇产科医师学会产前检测指征的985名孕妇,每周行超声生物物理评分(不含无应激试验)共3981次。异常评分的孕妇比例为1.6%(95%CI 1.0-2.6%),每次评分为0.4%(95%CI 0.3-0.7%);宫内胎儿死亡3例,假阴性率0.3%(95%CI 0.1-0.9%)。作者认为,在存在基础疾病的高危孕妇中,超声生物物理评分可用于产前检测。
要点
- 985名孕妇共行3981次超声生物物理评分,平均每人4次(范围1-11次)。
- 异常超声生物物理评分孕妇比例为1.6%(95%CI 1.0-2.6%),每次评分为0.4%(95%CI 0.3-0.7%)。
- 宫内胎儿死亡3例,假阴性率0.3%(95%CI 0.1-0.9%),从正常评分至胎儿死亡间隔分别为7、7、6天。
核心结论
- 在高危队列中,使用超声生物物理评分与极低的测试阳性率和极低的宫内胎儿死亡发生率相关。
- 对于存在基础疾病、宫内胎儿死亡风险较高的孕妇,超声生物物理评分可用于产前检测。
研究设计与样本
- 病例系列,回顾性审查2006至2018年间单一生殖医学实践机构中孕32周及以上、至少有一项美国妇产科医师学会产前检测指征的孕妇记录。
- 共纳入985名孕妇,共行3981次超声生物物理评分(平均每人4次,范围1-11次)。
- 从孕32周开始每周行超声生物物理评分(包含生物物理评分的所有组成部分,但不含无应激试验)。
主要发现
- 16名孕妇超声生物物理评分异常,孕妇水平的测试阳性率为1.6%(95%CI 1.0-2.6%),每次评分的测试阳性率为0.4%(95%CI 0.3-0.7%)。
- 16名评分异常的孕妇中,13名分娩且结局良好,3名后续检测正常并较晚日期顺利分娩。
- 3名孕妇发生宫内胎儿死亡,假阴性率为0.3%(95%CI 0.1-0.9%);从正常超声生物物理评分至宫内胎儿死亡的间隔分别为7、7、6天。
- 第1例宫内胎儿死亡孕妇合并因子V Leiden突变、胎儿脑室扩大和胎儿生长受限;第2例合并高龄、因子V Leiden突变和胎儿生长受限;第3例合并B级糖尿病。
临床怎么用
- 作者认为,对于存在基础疾病、宫内胎儿死亡风险较高的孕妇,超声生物物理评分可用于产前检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the utility of the ultrasonographic biophysical profile, which includes all the components of a biophysical profile minus the nonstress test, in women with maternal indications for antepartum surveillance. METHODS: We conducted a case series reviewing the records of all women at 32 weeks of gestation or greater with at least one indication for antenatal testing (per the American College of Obstetricians and Gynecologists) delivered by a single maternal-fetal medicine practice between 2006 and 2018. Indications included diabetes, hypertension, lupus, antiphospholipid syndrome, sickle cell disease, renal disease, heart disease, hyperthyroidism, isoimmunization, inherited thrombophilia, and prior intrauterine fetal demise. Weekly ultrasonographic biophysical profiles were initiated at 32 weeks of gestation. We calculated the test-positive rate, the percentage of women delivered for an abnormal ultrasonography biophysical profile, and the intrauterine fetal demise rate (false-negative rate). RESULTS: Nine hundred eighty-five women underwent 3,981 ultrasonographic biophysical profiles (four per woman; range 1-11). Sixteen women had an abnormal ultrasonographic biophysical profile, for a test positive rate of 1.6% (95% CI 1.0-2.6%) per woman, or 0.4% (95% CI 0.3-0.7%) per ultrasonographic biophysical profile. Of the 16 women with abnormal ultrasonographic biophysical profiles, 13 were delivered with good outcomes and three women had normal follow-up testing and uncomplicated deliveries at a later date. There were three women with intrauterine fetal demise (false-negative rate of 0.3%, 95% CI 0.1-0.9%). One woman with intrauterine fetal demise had a factor V Leiden mutation, fetal ventriculomegaly, and fetal growth restriction. The second woman with intrauterine fetal demise had advanced maternal age, a factor V Leiden mutation, and fetal growth restriction. The third woman with intrauterine fetal demise had class B diabetes. All three intrauterine fetal demises were diagnosed antepartum with an interval from normal ultrasonographic biophysical profile to intrauterine fetal demise of 7, 7, and 6 days, respectively. CONCLUSION: The use of ultrasonographic biophysical profile in a high-risk cohort is associated with a very low test-positive rate and a very low incidence of intrauterine fetal demise. In women with preexisting medical conditions that place them at higher risk for intrauterine fetal demise, ultrasonographic biophysical profile can be used for antenatal testing.
引用
- Zafman KB, Bruck E, Rebarber A, et al. Antenatal Testing for Women With Preexisting Medical Conditions Using Only the Ultrasonographic Portion of the Biophysical Profile. Obstet Gynecol. 2018. PMID: 30130352. doi:10.1097/AOG.0000000000002811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。